Our approach leverages innovative fabrication techniques and design principles to revolutionize regenerative medicine through personalized solutions. Key aspects include:
Utilizing cutting-edge computational tools to optimize scaffold designs and biomaterials, ensuring a precise mechanobiological fit for each patient's unique needs.
Harnessing 3D printing technologies to fabricate highly tailored, multi-material scaffolds with superior biofunctionality and cell-recruiting capabilities.
Employing advanced imaging technologies to map individual anatomical structures, enabling the creation of personalized biomimetic constructs that seamlessly integrate with native tissues.
Transforming advanced biomaterials into printable inks designed for additive manufacturing, enabling the creation of complex, patient-specific tissue scaffolds.
The InterLynk project is advancing beyond traditional approaches by investigating multimaterial constructs that ensure the structural and biochemical compatibility essential for effective tissue regeneration.
By integrating multiple materials into a single scaffold, we aim to address the distinct requirements of various tissues, ranging from the rigidity of hard bone to the flexibility of soft cartilage. These scaffolds are carefully designed to bridge the transitional zones that connect different tissue types.
Effective scaffolds must replicate the mechanical properties of native tissues to function seamlessly within the body. This includes providing the necessary strength for bone repair while preserving the elasticity crucial for cartilage regeneration.
InterLynk scaffolds support the biochemical signaling pathways that guide cell behavior and tissue growth. By fostering these interactions, our designs help promote natural tissue development, ensuring that the regeneration process aligns closely with the body’s intrinsic mechanisms
Scaffolds play a key role in bridging the gap between structural support and biological integration. InterLynk’s research explores how tailored designs and innovative materials can address dynamic body environments and complex medical challenges.
Designing patient-specific scaffolds involves more than structural replication; it requires anticipating how these constructs interact with the body over time. InterLynk’s research delves into how materials degrade within the body and how this influences tissue regeneration.
We focus on adapting scaffold designs to address the complexities of chronic conditions or intricate injuries where standard solutions often fall short. This comprehensive research aims to establish a robust framework for clinicians to develop scaffolds that not only meet immediate needs but also support long-term healing and functional restoration.
By integrating drug delivery systems tailored to individual patient needs, InterLynk scaffolds provide localized, controlled therapeutic release, transforming how complex injuries and chronic conditions can be treated.
Regenerative scaffolds are designed to do more than structurally support tissue—they actively enhance healing by incorporating therapeutic functions. InterLynk leverages innovative biomaterials, such as drug-loaded nanocarriers within platelet lysate-based matrices, to enable controlled, localized delivery of growth factors, anti-inflammatory agents, and antibiotics. This targeted approach maximizes therapeutic efficacy while minimizing systemic side effects.
The performance of drug delivery systems within scaffolds is closely tied to the materials and structures used. InterLynk explores how properties like porosity and mechanical reinforcement influence therapeutic release profiles. Advances such as porous and layered designs ensure sustained, sequential release of bioactive compounds, making scaffolds versatile tools for both regeneration and localized therapy.
Human-derived materials are at the forefront of InterLynk’s innovative approach, offering unparalleled biocompatibility and tailored regenerative solutions through the controlled release of bioactive compounds.
Platelet lysates, derived from human plasma, are rich in growth factors that promote cell proliferation, differentiation, and angiogenesis. Their controlled release enhances healing while minimizing risks like inflammation and cytotoxicity.
InterLynk combines platelet lysates with polymers to create hybrid scaffolds that mimic the extracellular matrix. These materials enhance mechanical strength, bioactivity, and adaptability for patient-specific applications.
Human-derived materials reduce cross-species contamination and meet strict ethical and regulatory standards. They ensure safer clinical use and support broader acceptance in regenerative medicine.